Clinically Relevant Response to Treatment with Olaparib in a Patient with Refractory Multidrug-Resistant Ovarian Cancer and Central Nervous System Involvement: A Case Report

Flavia Morales Vázquez; Horacio Noé López Basave; María del Carmen Méndez Herrera; Ricardo Raziel Peña González

doi:10.12659/AJCR.925990

23 November 2020: Articles

Clinically Relevant Response to Treatment with Olaparib in a Patient with Refractory Multidrug-Resistant Ovarian Cancer and Central Nervous System Involvement: A Case Report

Unusual or unexpected effect of treatment

Flavia Morales Vásquez ^A* , Horacio Noé López Basave ^B , María del Carmen Méndez Herrera ^B , Ricardo Raziel Peña González ^B

DOI: 10.12659/AJCR.925990

Am J Case Rep 2020; 21:e925990

Authors information Article notes Copyright and License information

View HTML version

Figure 3. Magnetic resonance imaging of the head 23 months after the first visit (A: Midline plane; B: Coronal plane). The arrows point to metastatic lesions.

Back to the Article

Clinically Relevant Response to Treatment with Olaparib in a Patient with Refractory Multidrug-Resistant Ovarian Cancer and Central Nervous System Involvement: A Case Report

Your Privacy